SharesGrow.com 标普和纳斯达克内在价值联系我们

हिन्दी

← 返回所有股票

Prelude Therapeutics Incorporated PRLD NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Analyst Price Target

Prelude Therapeutics Incorporated (PRLD) 有 12 个已识别的同行可供比较在 Healthcare 板块. 同行包括 ANTX, BCEL, BDTX, CCCC, CYT, ELYM 等.

PRLD 的市值为 $245.2M, 而同行平均市值为 $1.09B. PRLD 显著小于其平均同行.

同行与相似公司 — PRLD

AN2 Therapeutics, Inc.

$2.98 -1.00% $81.66M

$0.09 -1.32% $3.57M

Black Diamond Therapeutics, Inc.

$2.66 -2.21% $152.39M

C4 Therapeutics, Inc.

$2.76 +0.91% $228.6M

Cyteir Therapeutics, Inc.

$3.02 -2.27% $108.71M

Eliem Therapeutics, Inc.

$5.11 -0.97% $342.68M

Foghorn Therapeutics Inc.

$4.85 +3.41% $284.7M

Monte Rosa Therapeutics, Inc.

$17.50 -0.28% $1.14B

Kymera Therapeutics, Inc.

$89.87 +1.51% $7.34B

Mineralys Therapeutics, Inc.

$27.32 +0.59% $1.81B

Molecular Partners AG

$4.14 -1.66% $154.88M

Nurix Therapeutics, Inc.

$16.30 +2.45% $1.41B

其他人也在看

Revolution Medicines, Inc.

Kymera Therapeutics, Inc.

Mineralys Therapeutics, Inc.

Nurix Therapeutics, Inc.

Monte Rosa Therapeutics, Inc.

Eliem Therapeutics, Inc.

联系我们

🎓

SharesGrow 学院

学习如何计算内在价值，发现被低估的股票。

每周在线课程

📧 [email protected]

📞 +65 8912 8000

给我们留言